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Abstract  30 
The application of machine learning has recently gained interest from ecotoxicological 31 
fields for its ability to model and predict chemical and/or biological processes, such as 32 
the prediction of bioconcentration. However, comparison of different models and the 33 
prediction of bioconcentration in invertebrates has not been previously evaluated. A 34 
comparison of 24 linear and machine learning models is presented herein for the 35 
prediction of bioconcentration in fish and important factors that influenced 36 
accumulation identified. R2 and root mean square error (RMSE) for the test data (n = 37 
110 cases) ranged from 0.23 – 0.73 and 0.34 – 1.20, respectively. Model performance 38 
was critically assessed with neural networks and tree-based learners showing the best 39 
performance. An optimised 4-layer multi-layer perceptron (14 descriptors) was 40 
selected for further testing. The model was applied for cross-species prediction of 41 
bioconcentration in a freshwater invertebrate, Gammarus pulex. The model for G. 42 
pulex showed good performance with R2 of 0.99 and 0.93 for the verification and test 43 
data, respectively. Important molecular descriptors determined to influence 44 
bioconcentration were molecular mass (MW), octanol-water distribution coefficient 45 
(logD), topological polar surface area (TPSA) and number of nitrogen atoms (nN) 46 
among others. Modelling of hazard criteria such as PBT, showed potential to replace 47 
the need for animal testing. However, the use of machine learning models in the 48 
regulatory context has been minimal to date and is critically discussed herein. The 49 
movement away from experimental estimations of accumulation to in silico modelling 50 
would enable rapid prioritisation of contaminants that may pose a risk to environmental 51 
health and the food chain. 52 
Keywords modelling, PBT, pharmaceutical, bioconcentration, BCF, machine 53 
learning54 
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Introduction 55 
Both terrestrial and aquatic environments experience pollution from a wide 56 
range of chemical contaminants. The presence of these contaminants is a cause for 57 
concern as they may elicit adverse effects to environmental and public health. 58 
Bioaccumulation of chemicals is critically important for understanding the risk of 59 
chemicals in the environment. The complexity of confounding factors that affect uptake 60 
make simple relationships that can confidently predict the accumulation elusive; but it 61 
may not have to be that way.  62 
Live animal exposure studies are currently the norm, using many hundreds of 63 
fish for each assessment [1]. Across the European Union (EU), various guidelines 64 
have been established for industry to minimise the risk posed by their chemical 65 
products. For pharmaceuticals in the EU this is regulated by the European Medicines 66 
Agency (EMA) and for other chemicals substances the regulations are outlined by the 67 
Registration, Evaluation, Authorisation and restriction of CHemicals (REACH) [2, 3]. 68 
According to REACH, any manufacturer of a chemical that exceeds quantities of 10 69 
tonnes per annum must submit a chemical safety assessment (CSA). For 70 
environmental risk assessment, part of the CSA includes persistence, 71 
bioaccumulation and toxicity (PBT) assessments. Alternatively, for pharmaceuticals 72 
environmental risk assessment (ERA) follows an initial screening (Phase I) where 73 
physico-chemical properties of the compound are determined (e.g. logP) and the 74 
expected exposure is estimated. The Phase I exposure estimation is calculated as the 75 
predicted environmental concentration (PEC). If the PEC is >0.01 µg L-1 then the 76 
pharmaceutical must undergo further testing to assess environmental fate and toxicity. 77 
However, it should be noted that substances with a logP >4.5, will trigger a PBT 78 
assessment (following REACH guidelines) regardless of the Phase I PEC.   79 
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For PBT assessments, existing available screening data and prior assessment 80 
information are used to determine whether a chemical is bioaccumulative (B) or very 81 
bioaccumulative (vB) by estimation of a bioconcentration factor (BCF) or 82 
bioaccumulation factor (BAF). Currently, pharmaceuticals are not restricted or 83 
replaced as would normally be defined under REACH. Furthermore, whilst PBT 84 
assessments are implemented, the persistence and bioaccumulation outcome of 85 
these assessments are not taken into consideration for authorisation purposes, as no 86 
legal provisions specifically cover persistent, bioaccumulative and toxic  substances 87 
for pharmaceuticals [4].  88 
Laboratory testing for PBT brings with it a significant level of planning, quality 89 
control and cost [1]. Therefore, in silico methodologies to predict BCF or BAF offers a 90 
potential advantage to more intelligently use data to characterise potential exposure 91 
and risk. Quantitative Structure Activity Relationships (QSARs) are becoming 92 
increasingly popular within ecotoxicological fields as they represent, perhaps, the only 93 
realistically feasible scenario to assess the environmental risk of the several thousand 94 
chemicals that are available on the market [5]. In addition, such models can be used 95 
to ethically reduce or replace animal testing and falls under the replacement, reduction 96 
and refinement (3Rs) framework [6]. Further, effective in silico models could also be 97 
utilised to help shape future drugs in terms of ‘green by design’ ambitions [7]. 98 
More recently, more complex machine learning-based QSAR models involving 99 
artificial neural networks (ANNs), tree-based learners or support vector machines 100 
(SVMs) have been used to model BCF in fish [8-11]. However, several variations of 101 
machine learning-type models exist and wider applications of such models for 102 
bioaccumulation prediction have not yet been evaluated to identify any added benefits. 103 
Furthermore, current QSAR models have only been applied to modelling fish 104 
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bioaccumulation data and do not incorporate pharmaceutical data. The potential for 105 
application to other taxa such as invertebrates is also non-existent, mainly due to a 106 
shortage of available data.  107 
The aim of this work was to develop and critically evaluate several machine 108 
learning-based modelling tools for prediction of bioconcentration factor (BCF) in both 109 
a fish (Cyprinus carpio) and an invertebrate species (Gammarus pulex) for the first 110 
time. An open access fish BCF dataset was used in the first instance to build and 111 
compare 24 different models for 352 different compounds. Subsequently, the best 112 
model was applied to both a set of fish and invertebrate BCF data to assess its 113 
potential for cross-species prediction. The invertebrate dataset also contained mainly 114 
pharmaceuticals. In parallel, independent models were developed ab initio on a 115 
smaller set of invertebrate BCF data alone to assess the degree of commonality with 116 
the model developed on fish BCF data. Finally, the importance of molecular 117 
descriptors to understand the potential for a chemical to accumulate in biota was 118 
assessed. The use of such rapid and flexible modelling approaches is now critical to 119 
support the 3Rs, aid greener design and to help meet the demand for PBT 120 
assessments of potentially large numbers of compounds, which could be expanded to 121 
new and emerging environmental contaminants across different species.  122 
 123 
Materials and Methods 124 
Dataset generation and pre-processing  125 
Bioconcentration factors were collated from the European Chemical Industry 126 
Council Long-range Research Initiative (Cefic LRI) project EC07 in collaboration with  127 
European Academy for Standardisation e.V (EURAS) which established the BCF gold 128 
standard database across multiple fish species and is freely available at 129 
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http://ambit.sourceforge.net/euras/. BCFs were down-selected to reduce variability 130 
between different species and experimental conditions within the database. The BCF 131 
data used herein were specific to C. carpio and were included by the Chemicals 132 
Inspection and Testing Institute [12]. Out of all BCF data, this sub-selection resulted 133 
in the largest dataset with a single fish species (n=352) for modelling purposes. The 134 
reported BCFs represented whole-body values only and included pigments, 135 
pesticides, fungicides, herbicides, insecticides, polyaromatic hydrocarbons (PAHs) 136 
and polychlorinated biphenyls (PCBs), organochlorines, nitroaromatics, alkylphenols, 137 
aromatic hydrocarbons, organosulfurs and organotins. Approximately 36 % of the 138 
dataset contained ionisable compounds (estimated from ACD labs, Percepta 139 
software). The invertebrate BCF dataset (n=34) was collated from literature reported 140 
data [13-17] for the benthic freshwater organism, G. pulex. This species was selected 141 
as there was a relatively large amount of BCF data available when compared with 142 
other invertebrate species. For these, BCF data were only available for 143 
pharmaceuticals and pesticides and, again, represented whole-body values.  144 
Simplified molecular input line entry system (SMILES) strings were generated 145 
for each compound using Chemspider (Royal Society of Chemistry, UK). Molecular 146 
descriptors were generated from SMILES strings using Parameter Client (Virtual 147 
Computational Chemistry Laboratory, Munich, Germany), and ACD Labs Percepta 148 
(Advanced Chemistry Development Laboratories, ON, Canada). Approximately 450 149 
descriptors were initially generated covering constitutional, topological, geometrical 150 
and physico-chemical properties. The fish and invertebrate datasets were pre-151 
processed to remove any zero variance descriptors or descriptors that were 152 
erroneous. All BCF data used for modelling was log transformed for improved 153 
predictive accuracy. 154 
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 155 
Feature selection 156 
 Descriptors were down-selected using three different feature selection 157 
algorithms, the first of which was a genetic algorithm (GA). The GA parameters were 158 
set to population = 500, generations = 250, mutation rate = 0.1 and cross-over rate = 159 
1. The remaining two selection methods were part of stepwise regression which 160 
included a forward selection algorithm (FA) and backwards selection algorithm (BA). 161 
The feature selection algorithms used a generalised regression neural networks 162 
(GRNN) to monitor the error associated with the selected descriptors, where descriptor 163 
sets were optimised when the error showed no improvement. The use of GRNN for 164 
descriptor selection is very fast and requires minimal processing power. The 165 
performance of each feature selection algorithm was characterised by then testing 166 
several thousand neural networks and evaluating the predictive performance of the 167 
models based on the error of the predictions. The best feature selection method was 168 
the GA, which resulted in the down-selection of descriptors to a total of 14 that included 169 
6 topological descriptors; radial centric information index (ICR), Narumi harmonic 170 
topological function (Hnar), ramification index (Ram), superpendentic index (SPI), 171 
spanning tree number (STN), topological polar surface area (TPSA), 4 constitutional 172 
descriptors; number of hydrogens (nH), number of carbons (nC), number of nitrogens 173 
(nN), molecular weight (MW), 3 electrotopological descriptors; maximal 174 
electrotopological negative variation (MAXDN), maximal electrotopological positive 175 
variation (MAXDP), mean atomic Sanderson electronegativity (Me) and 1 physico-176 
chemical property; the octanol-water distribution coefficient (logD) (See SI, Table S3).   177 
 178 
Modelling approaches 179 
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Two different software packages were used to assess the applicability of 180 
several in silico models in predicting bioconcentration. Trajan 6.0 (Trajan Software 181 
Ltd., Lincolnshire, UK) was used to build and evaluate artificial neural networks. In 182 
addition, this software was also used for the feature selection and the same 183 
descriptors were used in both modelling software packages. Models developed and 184 
optimised in Trajan included generalised regression neural networks (GRNN), radial 185 
basis function networks (RBF) and 3-/4-layer multilayer perceptrons (MLP). Training 186 
of the MLPs used two training algorithms referred to as back propagation (BP) and 187 
conjugate gradient descent (CGD), models were trained for 100 iterations. The 188 
optimised model was a four-layer MLP. The first and fourth layers were the inputs 189 
(molecular descriptors) and outputs (logBCF), respectively. The second and third 190 
layers (hidden layers) contained 14 and 10 nodes, respectively. Regularisation was 191 
performed with the use of early stopping to prevent over-training of the dataset. 192 
Parameter tuning was performed by changing the number of hidden layers and nodes 193 
and assessing the model performance on the verification and test subsets. The 194 
subsets of cases presented to the neural networks were split so that 242 compounds 195 
(70 %) were used for training, 55 compounds (15 %) for verification and 55 compounds 196 
(15 %) for testing the networks. Normalisation of the input features showed no 197 
improvement in performance of the networks and training was performed without 198 
centred or scaled descriptors.  199 
In the second software package, modelling was performed using the R 200 
statistical computing language (freely available from https://www.r-project.org). Here, 201 
19 predictive models from different kinds of learner categories including both linear 202 
and non-linear models were trained and tested. These included, ordinary least-203 
squares regression (OLM, package: stats), partial least-squares (PLS, package: pls), 204 
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ridge regression (RR, package: elasticnet), elastic net (EN, package: elasticnet), 205 
quantile regression with LASSO penalty (QRL, package: rqPen) multivariate adaptive 206 
regression splines (MARS & B-MARS, package: earth), k-nearest neighbours 207 
regression (KNN, package: caret), extreme learning machines (ELM, package: 208 
elmNN), support vector machines with radial basis function (SVM-R, package: 209 
kernlab) and polynomial (SVM-P, package: kernlab) kernels, random forest exploiting 210 
classification and regression trees (RF-CART, package: randomForest) and 211 
conditional inference trees (RF-CIT, package: party) algorithms as base learners, 212 
boosted trees (BT, package: gbm) and Cubist regression (CR, package: Cubist). MLPs 213 
(3-5 layers) with 1 hidden layer (ANN-1HL, package: nnet), averaged 1 hidden layer 214 
(ANN-a1HL, package: nnet), 2 hidden layers (ANN-2HL, package: RSNNS) and 3 215 
hidden layers (ANN-3HL, package: RSNNS) were also tested. For this modelling 216 
approach, the same molecular descriptors and logBCF were used again as input and 217 
output variables. The dataset was split into two subsets, training data (70 %) and test 218 
data (30 %). Normalisation of the data was required for the modelling application and 219 
the dataset was both centred and scaled. Parameter tuning was performed by 220 
resampling of the training subset following a 10-fold cross-validation scheme repeated 221 
five times and implemented through the caret package. Performance of each model 222 
was assessed from the root-mean square error (RMSE) and the correlation coefficient 223 
(R2). The best model for each regression method was then selected, retrained on the 224 
entire training dataset and used to predict cases in the test dataset.  Final datasets 225 
used for modelling the optimised models are given in the SI (Table S1 & S2). The 226 
finalised models were all tested according to OECD guidelines [18] for QSAR model 227 
validation. 228 
 229 
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Results and Discussion 230 
 231 
Down-selection of input features for modelling BCFs in fish  232 
The down-selection of the input features was assessed using three different 233 
feature-selection algorithms. Stepwise methods that included forwards or backwards 234 
selection (FA/BA) reduced the number of descriptors from 180 down to 72, whilst the 235 
GA reduced the number of descriptors to 66. The GA showed better correlation 236 
between selected descriptors with logBCF compared to stepwise algorithms (Figure 237 
S1). For both BA and FA, the selection process converged to the same local minima 238 
indicating that there was no difference in using either algorithm. The improved 239 
performance of the GA is due to selection of descriptors from multiple points in the 240 
descriptor space, as opposed to FA or BA that start selection from a single point. Thus, 241 
approaching global minima is more likely to arise when using the GA over stepwise 242 
selection methods.  243 
From the 66 descriptors selected by the GA, the top 22 descriptors plus an 244 
additional two user curated descriptors were selected for further modelling (See SI, 245 
Table S3). These additional descriptors were logD and number of hydrogen acceptor 246 
groups (nHAcc) and were chosen for their previously demonstrated influence on 247 
accumulation in biota [19, 20]. All descriptors were then tested across several 248 
thousand MLPs (three and four-layer) where the Trajan software sub-selected the best 249 
from the group of 24 descriptors based on model performance (MLPs yielded the best 250 
performance over other model types in terms of R2 and RMSE). The descriptors were 251 
down-selected to a total of 14 that showed relatively good performance across MLPs 252 
tested and were subsequently used in both modelling approaches discussed herein 253 
(Table S3). Given the scale of BCF data used for training (n=242), the 5:1 Topliss 254 
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threshold set out by the OECD guidelines [18] for the ratio of numbers of cases to 255 
descriptors was acceptable at 17:1. 256 
 257 
Comparison of model performances for prediction of fish BCFs 258 
The results of both modelling approaches are shown in Table 1. For models 259 
trained in R, the highest RMSE values were observed for OLM (1.203), followed by 260 
PLS (1.164) and then QRL (1.112). The relatively poor performance of such linear 261 
models may be expected as modelling such a biologically complex process is not likely 262 
to follow linear relationships using simple molecular descriptors. Even with well-263 
studied descriptors, such as logP, there is a non-linear trend with accumulation over 264 
a specific threshold (generally, logP >6) [21]. However, when used as a sole 265 
descriptor, logP may exclude processes that are also important for accumulation. For 266 
example, elimination and metabolism rates may impact net accumulation as well as 267 
more specific physiology such as carrier mediated transport and protein binding [22] 268 
will also influence accumulation, especially for emerging contaminant classes such as 269 
pharmaceuticals. By comparison, better performance was achieved using higher 270 
complexity models. The lowest RMSEs were observed for RF-CART (0.771), followed 271 
by BT (0.789) and RF-CIT (0.821), i.e. three tree-based machine learners. Next, ANNs 272 
and SVMs performed very similarly to tree learners, e.g. SVM-R (0.841), ANN-a1HL 273 
(0.859) and ANN-3HL (0.880).  274 
Models tested in Trajan showed particularly good performance, in comparison 275 
to those built in R. The lowest RMSE value was observed for a 4-layer MLP (0.524), 276 
followed by 3-layer MLP (0.538), RBF (0.689), GRNN (0.893) and Linear (1.052). In 277 
absolute terms, definitive conclusions cannot be drawn from direct comparison of 278 
modelling approaches (i.e., Trajan vs. R), as tuning and training methods between 279 
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modelling software packages are slightly different. However, overall results converged 280 
to support the higher reliability of non-linear approaches for modelling logBCF from 281 
molecular descriptors. 282 
Model complexity does not necessarily mean better predictive performance by 283 
default, as several non-linear machine learners did not perform well at all. These 284 
included ELM and SVM-P, where the RMSE values observed on the test set were >1. 285 
Although ELM is a feedforward neural network, the weights associated with the 286 
neurons in the network are not updated and thus the initialisation of the network is a 287 
random selection of weights that may not model the output reliably. The EN 288 
outperformed QRL and RR models, where the EN is a combination of the penalties 289 
(L1 and L2 regularisation) used by both models that usually leads to better predictive 290 
performance. The RR model RMSE for the test set data was also lower than the RMSE 291 
for the QRL model. This can be observed when comparing RR and QRL methods, as 292 
the penalty associated with LASSO can lead to the omission of highly correlated 293 
covariables and thus lead to lower model robustness.  294 
Limitations of predictive performance may also stem from the raw data. For 295 
example, the dataset used herein did not report individual experimental pH, but instead 296 
reported a range from 6.0 to 8.5. Therefore, descriptors such as logD that require pH 297 
data may become limited and especially where molecular pKa lies within this 2.5 pH 298 
unit range. LogD has been shown in several works to influence uptake and 299 
accumulation [23-25]. As a compromise, we calculated logD at pH 7, but this may have 300 
been different to the exact experimental pH and may have added to predictive 301 
inaccuracy across the whole analyte set. Lastly, it is also likely that BCF/BAF 302 
prediction will be influenced by variance in biotic factors such as ventilation rates, age, 303 
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genetic factors and metabolism and lay beyond our ability to determine in more detail 304 
[26, 27].  305 
MLP models trained in Trajan offered the best performance. Consequently, this 306 
model was chosen for further investigation in line with the OECD validation guidelines 307 
to assess validity of QSAR modelling. The mean absolute error (MAE) corresponded 308 
to 0.38 logBCF units for the verification subset (internal validation set) and 0.53 309 
logBCF for the test subset (external validation set), as shown in Table 1. The RMSE 310 
for verification and test subsets were 0.524 and 0.644, respectively. The predictive 311 
performance of this model was better or comparable to all models in the literature that 312 
have attempted to model accumulation processes. Dearden and Shinnawei [28] used 313 
a linear QSAR approach to predict BCFs for 135 chemicals with an R2 of 0.637 and 314 
RMSE of 0.661 logBCF units. Another QSAR model by Sahu and Singh [29] used 315 
multiple linear regression to predict BCFs for 131 organic compounds with a RMSE of 316 
0.556 log units. However, this model was not validated against a test subset and 317 
therefore generalised applicability of the model performance is arguably limited.  318 
In alternative approaches to linear QSAR models, other machine learning 319 
approaches have also been reported [8-10]. A MLP predicted BCFs for 9 test 320 
compounds with an average absolute error of 0.33 ±0.22 log units [8]. Whilst the errors 321 
were low, too few compounds were tested to provide a reliable assessment of its 322 
generalisability. In another approach, Zhao et al., [10] used SVM, RBF and MLR 323 
models individually. Better performance was observed when two RBF models (using 324 
different descriptors) were combined into a ‘hybrid’ model to predict logBCF. The 325 
developed model showed an R2 of 0.6917 for an external test set with a reported 326 
RMSE of 0.69 logBCF units for 119 compounds showing similar performance to the 327 
fish-based MLP presented here, using a single MLP. The hybrid model also showed 328 
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a limitation in the training set, where several cases were not modelled correctly 329 
between the ranges of logBCF 4 to 5 and was observed by a plateau in the regression 330 
analysis.    331 
 332 
A remark on outliers and the applicability domain  333 
Training and testing of all models led to the observation of several common 334 
outliers. The reason for poor prediction for such cases may stem from under 335 
representation in the dataset used for modelling. The spread of input and output data 336 
between training and validation subsets showed that there was no significant 337 
difference between the spread or skew of the data (Figure S2). However, using PCA 338 
analysis and distances between the descriptor spaces there were several cases that 339 
did not cluster well with the remaining data (Figure 1a). For example, logBCF for 340 
perfluorotributylamine was predicted poorly across the majority of trained models. The 341 
use of PCA and descriptor data spacing in this way enabled characterisation of the 342 
applicability domain (AD) for a given model. A threshold may then be used to 343 
determine cases that fall outside the domain and are likely to have higher predictive 344 
error (Figure 1b) [30, 31].  345 
According to the OECD QSAR model validation guidance [18], consideration of 346 
models for regulatory purposes must be associated with a defined domain of 347 
applicability under Principle 3. However, one key consideration in the use of distance-348 
based ADs is that input descriptors are not used equally by the model [32]. Therefore, 349 
such ADs may not accurately identify those cases having a greater predictive error in 350 
every case. This was observed for outliers in the PCA analysis, but where logBCF was 351 
predicted relatively well and vice versa. For example, di-2-naphthyldisulfide was not 352 
an outlier in the AD but was poorly predicted across all models. On the other hand, 353 
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pigment yellow-12 was an AD outlier, but logBCF was predicted well by the majority 354 
of models.  355 
Poor predictive accuracy for molecularly similar compounds could be also 356 
caused by other factors such as poor quality raw data or too few representative training 357 
cases for the model to learn from. It has been shown previously that experimental BCF 358 
data can vary from 0.42 to 0.75 log units [9, 33, 34]. Nevertheless, even with the 359 
limitations associated with defining an AD, it is useful and important to identify any 360 
cases that might not be reliably predicted so that rapid prioritisation of compounds can 361 
begin. Only for these cases, may it then be appropriate to revert to experimental 362 
testing. 363 
 364 
Machine learning in a regulatory context 365 
Several of the developed machine learning tools in Table 1 showed potential 366 
for the replacement and reduction in animal use. However, it is important to recognise 367 
the complexities of machine learning approaches from the outset, especially where 368 
they are intended for use in regulation. Under Principle 2 of the OECD guidelines, 369 
models used in this way must be based on “unambiguous algorithms”. In particular, it 370 
is highlighted that two significant limitations exist regarding artificial neural networks, 371 
for example. These are: (a) the necessity for large (BCF) datasets to develop suitable 372 
models (which do not exist for some classes of compounds, like pharmaceuticals) and 373 
also (b) that these types of machine learning tools are more ambiguous than other 374 
types of model, especially those that are linear in nature. For the latter, the guidance 375 
is vague concerning appropriateness of ANNs for use under this specific principle but 376 
infers that it is an acceptable limitation. Furthermore, the definition of an unambiguous 377 
algorithm is in fact ambiguous and should be further refined to prevent confusion to 378 
17 
 
the reader. This principle could be applied in different ways to different models and 379 
may cover the generation of molecular descriptors, the feature selection algorithms 380 
used, the learning process (for machine learners where the ambiguity lies) and the 381 
final model [35]. The majority of the literature seems to have focused on linear models 382 
perhaps as a result, mainly to aid in mechanistic understanding and to allow expert 383 
interpretation of individual chemicals to provide extra assurance in predicted data 384 
(linked to Principle 5).  385 
Principle 5 of the OECD guidelines relates to mechanistic interpretability of 386 
QSAR models (if possible). This can be considered a limitation for machine learning 387 
algorithms if the aim is to achieve an interpretable model, such as would normally be 388 
expected of linear models such as OLS or PLS regression. The OECD guidelines also 389 
remain vague regarding mechanistic interpretation of machine learners. However, 390 
whist linear relationships may not be apparent, descriptor sensitivity analyses can 391 
indicate the importance of individual descriptors and thus enables interpretation of 392 
factors that influence the modelled process. Bioconcentration processes are not 393 
simple and extensive datasets are extremely impractical to curate experimentally. 394 
Therefore, complex non-linear models may provide a more rapid solution to regulatory 395 
decision-making meantime. Therefore, we suggest that guidelines for QSAR model 396 
validation need to be expanded to better define the scope of applicability of all the 397 
different types of machine learning tools and their fitness for purpose in a regulatory 398 
context.  399 
For PBT testing, the same regulations are triggered when a threshold for 400 
bioaccumulation is reached, regardless of the extent to which the threshold is 401 
exceeded. Thus, if the value is classified within the correct category of non-402 
bioaccumualtive (nB), bioaccumulative (B) or very bioaccumulative (vB), the model will 403 
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be useful in the context of PBT assessments. Variability in measurement can arise 404 
from kinetic modelling approaches [17], biological/physiological variability (age, health, 405 
lipid content etc.) [27, 36-39] and experimental conditions (pH, temperature, etc.) [23, 406 
40]. As such, reported BCFs have been shown to differ by 1-2 orders of magnitude 407 
even within the same species [27].  408 
The 4-layer MLP here showed a correct classification rate of 90 % across the 409 
verification and test subsets. The 10 % misclassification of cases was split to 6 % of 410 
cases predicted as false negatives and 4 % of cases predicted as false positives (See 411 
SI, Figure S3). This is consistent with the hybrid model developed by Zhao et al. which 412 
has shown classification accuracies ranging from 91 % to 98 % [9, 10]. It is possible 413 
that using QSARs for classification instead of regression analysis may improve the 414 
accuracy and without the need for the application of a bias. This would be particularly 415 
suitable for bioaccumulation assessments where only a threshold value determines 416 
the level of regulation enforced.  417 
Some studies have reported the application of models for classification of 418 
bioaccumulation thresholds, with accuracies ranging from 84.5 – 91.1 % (depending 419 
on model type) [41] and 91.7 % [11]. The authors that used tree-based learners also 420 
used these models for quantitative prediction achieving RMSE of 0.554 and R2 of 421 
0.836 on the test set data [11]. The models tested across the literature have tended to 422 
achieve similar performance for both classification and prediction. The agreement in 423 
performance between different works and the comprehensive model evaluation here, 424 
support that in silico methods should be adopted for chemicals where environmental 425 
uptake data are limited to enable flexible, cheap and rapid PBT assessment for 426 
compound prioritisation. Furthermore, it suggests that the use of chemical descriptors 427 
may only be able to achieve a certain level of predictive or classification performance 428 
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for modelling approaches where other variables become important as mentioned 429 
above.  430 
 431 
Can the developed model be used for cross phylum prediction?  432 
There is little understanding of whether accumulation will be similar across the 433 
invertebrate phylum. The dominant site of uptake for waterborne micropollutants in 434 
fish is across the gills and therefore accumulation across taxa may be significantly 435 
different for differing modes of respiration. Other factors such as size, enzyme 436 
speciation and lipid content may also influence the accumulation potential [27]. The 437 
optimised model for fish was applied to the prediction of logBCF in a freshwater 438 
invertebrate, Gammarus pulex (Figure 3a). The accumulation data in G. pulex 439 
predominantly covered pharmaceuticals and pesticides. The fish-based MLP showed 440 
relatively low predictive performance for the invertebrate accumulation factors. The 441 
correlation between observed and predicted BCF was R2 0.3295 with a MAE of 0.80 442 
±0.65 log units, which indicated that the model generalisations between species were 443 
limited. The largest predictive error was for the compound imipramine that was 444 
overestimated by 2.7 logBCF units. This compound in a previous study had 445 
considerable variation in the estimated BCF (212 – 4533) depending on the method 446 
of estimation used [17].  447 
 A significant difference in BCFs between trophic levels has been shown with 448 
higher trophic levels displaying increased BCFs [42]. This trend would suggest that 449 
the BCF predictions of the invertebrates might be overestimated but the opposite was 450 
observed (62 % of cases were underestimated). In addition to the biological complexity 451 
between species, another confounding factor to affect the predictive accuracy and 452 
generalisability is the compound class. The fish model included no pharmaceutical 453 
20 
 
compounds whereas the invertebrate BCF data contained 18 cases (~53%). 454 
Inspection of the molecular similarity between the datasets indicated that the 455 
invertebrate and fish datasets were dissimilar (Figure S4). Thus, the bioconcentration 456 
potential may not follow the same relationships with neutral hydrophobic organic 457 
contaminants.  458 
The fish-based model was subsequently reinitialised and trained on the 459 
invertebrate dataset only (using the same descriptors) (Figure 3b). The invertebrate 460 
model showed good correlation with R2 of 0.9605 with 0.972 for the training set, 0.9932 461 
for the verification set and 0.9323 for the test set. The model demonstrated good 462 
accuracy across the verification and test subset with a MAE of 0.07 ±0.08 logBCF 463 
units for the verification set and 0.29 ±0.27 logBCF units for the test set. The 464 
successful retraining of the model to invertebrate data suggests that case 465 
representation (i.e. compound class) is likely to limit models that are applied across 466 
taxa. An alternative approach to overcome this could involve development of a model 467 
with two or more outputs to represent different species, but commonality in BCF cases 468 
would be required for both species.  Whilst the predictive accuracy of the retrained 469 
model was very good, it is also limited by the small number of cases used. 470 
Generalisability is also likely to be limited given the ratio of cases to descriptors 471 
(Topliss ratio of ~2.5:1) Nevertheless, and as new BCF data emerges, this approach 472 
holds excellent potential by using the same molecular descriptors for BCF predictions 473 
in two very different species. In addition, to using the fish-based model to predict 474 
invertebrate BCFs we also used the invertebrate-based model to predict fish BCFs of 475 
pharmaceuticals reported in the literature (Figure S5). The invertebrate model was 476 
able to predict BCFs within the reported range for 45 % of the compounds selected (n 477 
= 11).  The remaining compounds, with the exception of sertraline and gemfibrozil, 478 
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were predicted relatively well even though they were not within the reported ranges. 479 
Sertraline is an interesting case as although it has not shown very high 480 
bioconcentration in fish (BCFs: <1 – 626) [43-47] there have been reported BCF values 481 
of up to 32,022 in invertebrates (namely, Lasmigona costata [48] and 990 in Planorbid 482 
sp. [49]). As the model used here was trained on BCFs from an invertebrate species, 483 
it may not correlate well with fish BCF data, suggesting that cross-phylum predictive 484 
modelling may be limited by both case representation and biological variation. 485 
However, as the models here used the same descriptors this enables flexibility in 486 
retraining optimised models and inevitably as more BCF data is generated for the 487 
same compounds in different species, this technology could be used to map 488 
accumulation across taxa more effectively. It is critically important to understand 489 
uptake (internal concentration) across taxa as the conservation of pharmaceutical 490 
targets extends widely [50]. 491 
 492 
Model sensitivity to descriptors: interpreting accumulation through chemistry 493 
Whilst machine learning models are more difficult to interpret due to the non-494 
linear functionality, collinearity and/or curvilinearity; the importance of the 14 495 
descriptors described here still offered some mechanistic understanding of the 496 
processes involved (Figure 4). For the fish-based model, the most important descriptor 497 
was TPSA with an error ratio of 2.08. Higher error ratios correspond to increased 498 
predictive error for all compounds upon removal of this descriptor from the dataset. 499 
Previous investigations have demonstrated that descriptors related to polarisability, 500 
hydrophobicity and hydrogen bonding of the molecule is important to modelling BCFs 501 
[10, 28, 51]. TPSA is defined as the surface area occupied by nitrogen and oxygen 502 
atoms including connected hydrogen atoms [52]. Polar surface area has also been 503 
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shown to influence drug absorption in humans, where increasing polar surface area 504 
decreases the drug fraction absorbed [19, 53]. The relationship between 505 
bioconcentration and TPSA may be dependent on several factors such as permeation 506 
through the lipid bilayer, binding of polar functional groups to epithelial membranes 507 
and the size of hydration shell around a molecule [54].  508 
Permeation through cellular membranes was further supported by the 509 
importance of MW to the model. The size of a molecule also affects permeation and 510 
diffusion through membranes (Lipinski’s rule of five [55]). It has previously been 511 
demonstrated that dye pigments did not show bioaccumulation in fish due to their large 512 
molecular size [56]. In another study, it was suggested that there is a threshold 513 
diameter value of 1.5 nm which governed bioconcentration in addition to 514 
hydrophobicity [57].  Strempel et al., [11] also found that molecular weight, molecular 515 
diameter, TPSA and logD were important for classification and prediction of 516 
bioaccumulation.  517 
Topological descriptors such as STN, Hnar, Ram, SPI and ICR were also found 518 
to be important. These indices are useful especially for differentiating constitutional 519 
isomers (except enantiomers) [58]. Error ratios for STN, Hnar, ICR, SPI and Ram 520 
spanned from 1.31 – 1.72. These indices are related to molecular branching/shape 521 
and the importance of these descriptors relate to molecular size which can influence 522 
bioconcentration [59, 60]. MAXDN and MAXDP relate to the partial charges on atoms 523 
relative to their topological position within the molecule and therefore relate to the 524 
nucleophilicity and electrophilicity of a molecule [61]. Aside from polarity-related 525 
accumulation across cellular membranes, it is also possible that these are associated 526 
with metabolic activity (from nucleophilic or electrophilic attack). The importance of 527 
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other electrotopological descriptors (along with molecular flexibility) has been 528 
previously shown for modelling bioconcentration [62].  529 
Interpretation of the relative importance of descriptors is affected by collinearity 530 
or multicollinearity (See SI, Table S4 & S5). The collinearity of the descriptors showed 531 
that molecular weight was collinear with SPI (R=0.794) and Ram (R=0.696). The 532 
descriptor Ram was also collinear with SPI (R=0.787) and STN was collinear with 533 
HNar (R=0.748). The relation between these topological descriptors and molecular 534 
weight is that they all describe molecular size (shape, volume, weight) to some extent. 535 
Therefore, the rank importance of these particular descriptors should be approached 536 
with some caution. Whilst the error ratio is higher for certain descriptors that are 537 
collinear, their removal from the network model may not correctly determine the ratio 538 
value due to redundant information. Nevertheless, the descriptor sensitivity can still be 539 
useful for directing mechanistic and experimental studies. This was shown recently in 540 
a neural network application to passive sampling [63] which was later followed by a 541 
mechanistic study [64], that supported the interpretation of the model.  542 
The invertebrate-based MLP used the same descriptors as the fish-based 543 
model, but the network was reinitialised and retrained. The retraining of the network 544 
also showed that the importance of the descriptors changed from the fish-based 545 
model. The most important descriptor was HNar (error ratio = 5.75) followed by nN 546 
(error ratio = 5.09) and logD (error ratio = 4.71). The increased importance of the 547 
number of nitrogen atoms likely reflected the number of pharmaceutical compounds 548 
in the dataset. In addition, logD increased in rank to the top three descriptors in the 549 
invertebrate model. The increased sensitivity of the model to logD also relates to 550 
training of the model with ionisable pharmaceuticals and is in agreement with other 551 
studies showing logD to be important in accumulative processes [11, 64].  Whilst 552 
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hydrophobicity may be a principal factor of bioconcentration, it is possible that carrier-553 
mediated transport may also play an important role. Both models here demonstrated 554 
that other variables also strongly influence BCF prediction. Thus, QSAR models that 555 
rely solely on logP or logD in our opinion are limited in their application.  556 
It is important to consider that descriptors not used in this work may also have 557 
a potential for BCF modelling. For example, the major mechanism of transport across 558 
epithelia tissue is passive diffusion and so it is also possible that diffusion coefficients 559 
could potentially be an important descriptor for consideration among others, however 560 
these descriptors are difficult to acquire and therefore reduce the practicability of a 561 
model based on these.  562 
Conclusions 563 
The work presented herein has shown that in silico modelling approaches are 564 
a powerful approach to predict bioconcentration of environmental contaminants, 565 
enabling rapid prioritisation of compounds during ERA. The approach could be used 566 
to better understand bioaccumulation, and the molecular descriptors that drive it; 567 
moving the science beyond simple hydrophobicity models that poorly account for the 568 
complexity of pharmaceuticals.  Cross-species prediction of accumulation warrants 569 
further investigation as the results indicate both case representation and biological 570 
variability might limit prediction of accumulation between different taxonomic groups. 571 
Nevertheless, the use of machine learning has been increasing within the field and is 572 
necessary to improve our understanding of biological processes that affect 573 
environmental health. The interpretation of descriptors here is critical as it 574 
demonstrates that, in addition to rapid prediction of bioconcentration factors, in silico 575 
models are useful for mechanistic understanding which in turn can be used to direct 576 
further work. This is particularly true for pharmaceutical uptake in biota, where the 577 
25 
 
mechanisms that govern uptake, elimination and accumulation processes are still not 578 
fully understood. Excellent potential exists for rapid screening using machine learning 579 
technology in future ERA, without the need for costly and ethically challenging animal 580 
experiments. Finally, the OECD QSAR validation guidelines for machine learners are 581 
inexplicit and we suggest these guidelines should be expanded with more focus on 582 
this type of modelling approach. This will begin to address the applicability and 583 
usefulness of these models for regulatory schemes such as REACH where PBT 584 
assessments are required for several thousand chemicals. 585 
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  RMSE R2 MAE 
  Model Training Verification Test Training Verification Test Training Verification Test 
Trajan Linear 0.785 1.052 0.832 0.532 0.390 0.521 0.619 0.835 0.608 
 GRNN 0.830 0.893 0.873 0.673 0.400 0.569 0.664 0.893 0.718 
 RBF 0.723 0.689 0.584 0.651 0.635 0.725 0.565 1.600 0.450 
 3-MLP 0.689 0.538 0.337 0.675 0.770 0.659 0.548 1.608 0.553 
  4-MLP 0.403 0.524 0.644 0.887 0.819 0.702 0.313 0.380 0.530 
  Model Training Cross-Validation Test Training Cross-Validation Test Training Cross-Validation Test 
R OLM 0.719 0.771 1.203 0.621 0.570 0.234 0.560 NA 0.778 
 PLS 0.722 0.769 1.164 0.618 0.571 0.254 0.564 NA 0.765 
 RR 0.725 0.766 1.083 0.614 0.576 0.304 0.568 NA 0.753 
 EN 0.729 0.760 1.054 0.612 0.582 0.314 0.577 NA 0.754 
 QRL 0.733 0.757 1.112 0.607 0.585 0.284 0.562 NA 0.770 
 KNN 0.517 0.683 0.902 0.807 0.665 0.468 0.404 NA 0.648 
 ELM 0.673 0.756 1.014 0.668 0.593 0.346 0.529 NA 0.768 
 ANN-1HL 0.596 0.751 0.877 0.739 0.597 0.505 0.462 NA 0.620 
 ANN-a1HL 0.395 0.672 0.859 0.888 0.678 0.518 0.319 NA 0.612 
 ANN-2HL 0.232 0.834 1.022 0.962 0.560 0.370 0.174 NA 0.680 
 ANN-3HL 0.454 0.795 0.880 0.860 0.582 0.520 0.345 NA 0.624 
 MARS 0.539 0.730 1.014 0.787 0.632 0.390 0.425 NA 0.696 
 B-MARS 0.500 0.681 0.899 0.819 0.673 0.479 0.395 NA 0.633 
 SVM-R 0.383 0.644 0.841 0.893 0.704 0.537 0.261 NA 0.590 
 SVM-P 0.699 0.747 1.029 0.643 0.594 0.340 0.539 NA 0.729 
 RF-CART 0.292 0.675 0.771 0.956 0.688 0.633 0.231 NA 0.589 
 RF-CIT 0.605 0.739 0.821 0.762 0.630 0.586 0.485 NA 0.652 
 BT 0.249 0.660 0.789 0.957 0.687 0.593 0.187 NA 0.587 
 CR 0.353 0.678 0.973 0.910 0.673 0.431 0.282 NA 0.628 
Table 1: Comparison of model performance for the prediction of BCF in Cyprinus carpio. MAE is the mean absolute error and NA 
indicates the metric was not applicable.  
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Figure 1: (a) Principal component analysis used for visualisation of the case similarity based 
on the 14 modelled descriptors (i.e. applicability domain). (b) Distances between cases in the 
PCA space with a threshold applied (0.975 quantile of χ2 distribution) designated by the red 
line (c) the distribution of cases based on distance in the PCA space.  
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Figure 2: (a) linear regression of the predicted logBCF values versus the observed logBCF 
values in fish using the 4-MLP developed in approach 1, training data (crosses, n = 242), 
verification data (circles, n = 55) and test data (triangles, n = 55). (b) Raw residuals of the 
predicted logBCF data in fish for the verification and test data only.    
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Figure 3: (a) Comparison of the predicted logBCF data versus the observed logBCF in 
invertebrates using the fish-based 4-layer MLP. (b) Regression of a separately developed and 
optimised model trained with the invertebrate BCF data (Gammarus pulex), training set 
(crosses, n = 24), verification set (circles, n = 5) and test set (triangles, n = 5) 
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Figure 4: Descriptors sensitivity analysis performed by removing a descriptor from the model 
and assessing the affected performance. Increased error ratios indicate more important 
descriptors. (a) descriptor sensitivity for the fish-based model and (b) for the invertebrate-
based model.  
 
 
